NEVVI Medicare utilization intelligence
or

← back

Provider profile

MILLER, DEREK MMS, PA-C

Physician Assistant · NPI 1124491212 · DENVER, CO

3
Groups
15
Codes · 2024
605
Disclosed services

MILLER, DEREK is a Physician Assistant in DENVER, CO, a member of 3 medical groups, who billed 15 distinct codes to Medicare Part B in 2024.

Groups: MEDSTAR MEDICAL GROUP II LLC (WASHINGTON, DC) · MEDSTAR URGENT CARE LLC (WALDORF, MD) · URGENT CARE SOLUTIONS GLENDALE PC (DENVER, CO) — member of 3 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

605
disclosed services
15
codes billed to Medicare Part B
Prior year · CY2023 419 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
87798 Detection test by nucleic acid for organism, amplified probe technique
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
87804 Detection test by immunoassay with direct visual observation for influenza virus
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
81003 Automated urinalysis test
87481 Detection test for candida species (yeast), amplified probe technique
87641 Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique
87653 Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
87640 Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.